CHRONIC MYELOMONOCYTIC LEUKEMIA-1
Clinical trials for CHRONIC MYELOMONOCYTIC LEUKEMIA-1 explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOMONOCYTIC LEUKEMIA-1 trials appear
Sign up with your email to follow new studies for CHRONIC MYELOMONOCYTIC LEUKEMIA-1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Race to find better treatment for High-Risk blood cancers
Disease control OngoingThis study is testing whether adding one of two other drugs (lenalidomide or vorinostat) to the standard chemotherapy drug azacitidine works better for people with higher-risk myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML). The goal is to see which comb…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA-1
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New Two-Drug attack on tough blood cancers
Disease control OngoingThis study is testing a two-drug combination for adults with certain advanced blood cancers, including chronic myelomonocytic leukemia (CMML). The goal is to find the safest and most effective dose of a targeted drug (tagraxofusp) that delivers a toxin directly to cancer cells, c…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA-1
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC